Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


05.06.2017

2 Ann Surg Oncol
4 Anticancer Res
1 Br J Cancer
1 Br J Surg
4 Cancer
1 Gastrointest Endosc
2 Int J Cancer
1 J Natl Cancer Inst
1 J Surg Oncol
1 N Engl J Med
1 Oncogene
3 Oncol Rep
1 PLoS Biol
1 PLoS Genet
4 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. D'ANGELICA MI
    Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?
    Ann Surg Oncol. 2017 May 31. doi: 10.1245/s10434-017-5908.
    PubMed     Text format    

  2. SIMPSON AL, Doussot A, Creasy JM, Adams LB, et al
    Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5896.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. GOGENUR M, Hillig T, Gogenur I
    CytoTrack Analysis Reveals Low Presence of Circulating Tumor Cells in the Perioperative Period in Patients with Non-metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:3099-3103.
    PubMed     Text format     Abstract available

  4. YUN S, Han YS, Lee JH, Kim S, et al
    Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Anticancer Res. 2017;37:2975-2984.
    PubMed     Text format     Abstract available

  5. JEONG KY, Park M, Kim IU, Sim JJ, et al
    Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation.
    Anticancer Res. 2017;37:2959-2964.
    PubMed     Text format     Abstract available

  6. GONG J, Chen Y, Yang L, Pillai R, et al
    MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines.
    Anticancer Res. 2017;37:2831-2838.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. ALNABULSI A, Swan R, Cash B, Alnabulsi A, et al
    The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
    Br J Cancer. 2017 May 30. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Surg

  8. ARONSSON M, Carlsson P, Levin LA, Hager J, et al
    Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.
    Br J Surg. 2017 May 31. doi: 10.1002/bjs.10536.
    PubMed     Text format     Abstract available


    Cancer

  9. MOWERY YM, Salama JK, Zafar SY, Moore HG, et al
    Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Cancer. 2017;123:1434-1441.
    PubMed     Text format     Abstract available

  10. FRANKEL TL, Vakiani E, Nathan H, DeMatteo RP, et al
    Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.
    Cancer. 2017;123:568-575.
    PubMed     Text format     Abstract available

  11. CASSIDY RJ, Liu Y, Patel K, Zhong J, et al
    Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cancer. 2017;123:783-793.
    PubMed     Text format     Abstract available

  12. SAHLMANN CO, Homayounfar K, Niessner M, Dyczkowski J, et al
    Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
    Cancer. 2017;123:638-649.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  13. PARODI A, Vanbiervliet G, Hassan C, Hebuterne X, et al
    Colon Capsule to Screen for Colorectal Neoplasia in Subjects with a Family History of Colorectal Cancer.
    Gastrointest Endosc. 2017 May 26. pii: S0016-5107(17)31926.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. WANG N, Lu Y, Khankari NK, Long J, et al
    Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30812.
    PubMed     Text format     Abstract available

  15. OKAZAKI S, Stintzing S, Sunakawa Y, Cao S, et al
    Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30810.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  16. RUERS T, Van Coevorden F, Punt CJ, Pierie JE, et al
    Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    J Surg Oncol

  17. EMILE SH, Elfeki H, Shalaby M, Sakr A, et al
    Sensitivity and specificity of indocyanine green near-infrared fluorescence imaging in detection of metastatic lymph nodes in colorectal cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24701.
    PubMed     Text format     Abstract available


    N Engl J Med

  18. ESFAHANI K, Miller WH Jr
    Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    N Engl J Med. 2017;376:1989-91.
    PubMed     Text format    


    Oncogene

  19. KRAMER N, Schmollerl J, Unger C, Nivarthi H, et al
    Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Oncogene. 2017 May 29. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  20. CHEN LG, Xia YJ, Cui Y
    Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5666.
    PubMed     Text format     Abstract available

  21. WANG W, Deng J, Wang Q, Yao Q, et al
    Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Oncol Rep. 2017 May 25. doi: 10.3892/or.2017.5671.
    PubMed     Text format     Abstract available

  22. CUYAS E, Queralt B, Martin-Castillo B, Bosch-Barrera J, et al
    EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5682.
    PubMed     Text format     Abstract available


    PLoS Biol

  23. JUNEJA M, Kobelt D, Walther W, Voss C, et al
    Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.
    PLoS Biol. 2017;15:e2000784.
    PubMed     Text format     Abstract available


    PLoS Genet

  24. NIELSEN SV, Stein A, Dinitzen AB, Papaleo E, et al
    Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations.
    PLoS Genet. 2017;13:e1006739.
    PubMed     Text format     Abstract available


    PLoS One

  25. PARK JY, Kim SH, Lee SM, Lee JS, et al
    CT volumetric measurement of colorectal cancer helps predict tumor staging and prognosis.
    PLoS One. 2017;12:e0178522.
    PubMed     Text format     Abstract available

  26. LI J, Li Y, Liu H, Liu Y, et al
    The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    PLoS One. 2017;12:e0178515.
    PubMed     Text format     Abstract available

  27. OSUMI H, Shinozaki E, Suenaga M, Wakatsuki T, et al
    Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
    PLoS One. 2017;12:e0176745.
    PubMed     Text format     Abstract available

  28. KNUDSEN KN, Lindebjerg J, Nielsen BS, Hansen TF, et al
    MicroRNA-200b is downregulated in colon cancer budding cells.
    PLoS One. 2017;12:e0178564.
    PubMed     Text format     Abstract available


    World J Surg

  29. TORREJON B, Cristobal I, Rojo F, Garcia-Foncillas J, et al
    Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.
    World J Surg. 2017 May 30. doi: 10.1007/s00268-017-4065.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: